Dr. Birkeland’s research focus is translating novel clinical and basic research findings directly to patient care. To this end, he utilizes next generation sequencing, immune profiling, biomarker identification, and animal models to understand the causes of and treatments for head and neck cancers. His overarching aim is to advance precision medicine: providing personalized, optimized treatments for each head and neck cancer patient.